All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Blood flow between heart chambers is regulated by native valves—the mitral valve, the aortic valve, the pulmonary valve, and the tricuspid valve. Each of these valves are passive one-way valves which open and close in response to differential pressures. Patients with valvular disease have abnormal anatomy and/or function of at least one valve. For example, a valve may suffer from insufficiency, also referred to as regurgitation, when the valve does not fully close and allows blood to flow retrograde. Valve stenosis can cause a valve to fail to open properly. Other diseases may also lead to dysfunction of the valves. While medications may be used to treat the disease, in many cases the defective valve may need to be repaired or replaced at some point during the patient's lifetime. Existing valves and surgical repair and/or replacement procedures may have relatively high risks, limited lifespans, and/or be highly invasive. Some less-invasive transcatheter options are available, however these generally are limited to aortic valve procedures, are limited in patient-to-patient flexibility, and often take longer than is desirable to implant. It would therefore be desirable to provide a less invasive procedure for repair and replacement of heart valves, including the mitral valve, quicker surgical methods, and/or prosthetic valves that can accommodate a variety of individual patients.
Additionally, existing valve repair/replacement procedures are often complicated and time-consuming. Presently-available procedures often require the placement of more than one component—for example, a prosthetic valve and a mechanism to anchor it to the native anatomy. Such procedures generally utilize multiple delivery catheters to carry the various components and delivery of each component separately to the valve, which can be time-consuming (particularly if components are delivered sequentially), complicated, and/or dangerous. For example, some devices provide rotational anchoring elements to capture the native anatomy such as the chordae tendineae in order to reduce delivery time. However, such anchoring elements, often by design, capture and pull the chordae along during their rotation, which can torque or otherwise stress and damage the chordae during deployment of the anchor elements, resulting in the need for additional medical interventions for the patient. Moreover, such anchoring elements may require extrusion from a low-profile (e.g., elongated) delivery configuration to an expanded configuration at or near the native valve. In at least some instances, extrusion of the anchoring elements can be complicated and may not reliably deploy into the correct expanded configuration relative to the delivery device and/or the native anatomy. Incorrect deployment may result in additional time to retract and re-deploy the anchoring element, more complicated anchoring procedures, and/or damage to the native tissue. It would therefore be desirable to provide quicker, less-complicated, less dangerous, and more reliably deployable valve assemblies for valvular replacement and repair.
In general, in one embodiment, a delivery system for delivering a spiral anchor to a diseased native valve of a heart includes an anchor control catheter and an anchor guide extending from the anchor control catheter. The anchor guide includes a flexible configuration and a rigid configuration. The anchor guide in the rigid configuration includes a proximal section, a middle section, and a distal section. The proximal section includes a straight central axis and extends from the anchor control catheter, the middle section spirals axially and radially outwards from the central axis, and the distal section curves concentrically about the central axis in a plane that is perpendicular to the central axis.
This and other embodiments can include one or more of the following features. The anchor guide can include a plurality of cuts configured to define a shape of the guide in the rigid configuration. The plurality of cuts can include window cuts, interlocking spiral cuts, or toothed wedge cuts. The delivery system can further include one or more actuation elements configured to actuate the guide from the flexible configuration to the rigid configuration. The one or more actuation elements can include a nested concentric shaft mechanism or one or more pullwires or cables. The anchor guide can include an intermediate shape-set configuration configured to bias or urge the anchor guide towards the rigid configuration. The anchor guide can include a shape memory material. The anchor guide can include a central channel configured to hold an anchor therein. The anchor guide can be configured to deflect the anchor positioned within the central channel when the anchor guide is transitioned from the flexible configuration to the rigid configuration. The anchor guide can be configured to position the anchor concentrically relative to a central axis of the anchor control catheter. The anchor guide in the flexible configuration can be configured to be positioned within a delivery sheath.
In general, in one embodiment, a method of delivering a valve prosthesis to a diseased native valve of a heart includes positioning a delivery catheter in a first chamber of the heart, actuating an anchor guide of the delivery catheter from a flexible configuration to a rigid configuration, releasing an anchor from within the anchor guide, moving the delivery catheter from the first chamber to a second chamber of the heart such that the anchor guide in the rigid configuration is within the second chamber and the anchor is positioned concentrically relative to central axis of the delivery device, and rotating the anchor guide in the rigid configuration about the central axis so as to rotate the anchor and encircle chordae of the native heart with the anchor.
This and other embodiments can include one or more of the following features. The method can further include delivering a valve frame within the anchor after the step of rotating the anchor guide. Delivering the valve frame can include delivering the valve frame from a separate valve delivery catheter. A distal section of the anchor guide can curve concentrically relative to the central axis when the anchor guide is in the rigid configuration. Releasing the anchor can include releasing the anchor concentrically relative to the central axis. The method can further include adjusting a placement of the anchor with the anchor guide after the step of rotating the anchor guide. Adjusting the placement can include placing torque on the anchor with the anchor guide. Adjusting the placement can include moving the anchor proximally towards a valve annulus with the anchor guide. The diseased native valve can be a mitral valve, the first chamber can be an atrium, and the second chamber can be a ventricle. The method can further include counter-rotating the anchor guide during the step of moving the delivery catheter from the first chamber to the second chamber. An entirety of the anchor can be positioned within the second chamber and not the first chamber after the step of moving the delivery catheter from the first chamber to the second chamber. Releasing the anchor from within the anchor guide can include releasing the anchor while the anchor guide is in the rigid configuration. Releasing the anchor from within the anchor guide can include releasing the anchor while the anchor guide is an intermediate shape set configuration, and the releasing step can occur before the step of actuating an anchor guide of the delivery catheter from a flexible configuration to a rigid configuration.
In general, in one embodiment, a delivery system for delivering a spiral anchor to a diseased native valve of a heart includes an anchor control catheter and an anchor guide extending from the anchor control catheter. The anchor guide has a flexible configuration and a rigid configuration. The anchor guide in the rigid configuration includes a proximal section, a middle section, and a distal section. The proximal section extends from the anchor control catheter, the middle section includes an inversion, and the distal section is concentrically wrapped about the proximal section.
This and other embodiments can include one or more of the following features. The anchor guide can include a plurality of cuts configured to define a shape of the guide in the rigid configuration. The plurality of cuts can include window cuts, interlocking spiral cuts, or toothed wedge cuts. The delivery system can further include one or more actuation elements configured to actuate the guide from the flexible configuration to the rigid configuration. The one or more actuation elements can include a nested concentric shaft mechanism or one or more pullwires or cables. The anchor guide can include an intermediate shape-set configuration configured to bias or urge the anchor guide towards the rigid configuration. The anchor guide can include a shape memory material. The anchor guide can include a central channel configured to hold an anchor therein. The anchor guide can be configured to deflect the anchor positioned with the central channel when the anchor guide transitions from the flexible configuration to the rigid configuration. The anchor guide can be configured to position the anchor concentrically relative to a central axis of the anchor delivery catheter. The anchor guide in the flexible configuration can be configured to be positioned within a delivery sheath. The delivery system can further include an outer sheath positioned over the anchor control catheter and configured to house a prosthetic valve therein. The outer sheath can be configured to be retracted proximally to allow the prosthetic valve to self-expand around the anchor guide.
In general, in one embodiment, a method of delivering a valve prosthesis to a diseased native valve of a heart includes positioning a delivery catheter in a first chamber of the heart, actuating an anchor guide of the delivery catheter from a flexible configuration to a rigid configuration, releasing an anchor from within the anchor guide while the anchor guide is in the rigid configuration, moving the delivery catheter from the first chamber to a second chamber of the heart such that the anchor guide is inverted within the second chamber and the anchor is positioned concentrically around the delivery catheter, and rotating the anchor guide so as to rotate the anchor and encircle chordae of the native heart with the anchor.
This and other embodiments can include one or more of the following features. The method can further include delivering a valve frame within the anchor after the step of rotating the anchor guide. Delivering the valve frame can include delivering the valve frame from within the delivery catheter. Delivering the valve frame can include delivering the valve frame from a separate valve delivery catheter. A distal section of the anchor guide can wrap concentrically about a proximal section of the anchor guide when the anchor guide is in the rigid configuration. Releasing the anchor can include releasing the anchor concentrically relative to the delivery catheter. The method can further include adjusting a placement of the anchor with the anchor guide after the step of rotating the anchor guide. Adjusting the placement can include placing torque on the anchor with the anchor guide. Adjusting the placement can include moving the anchor proximally towards a valve annulus with the anchor guide. The diseased native valve can be a mitral valve, the first chamber is an atrium, and the second chamber is a ventricle. The method can further include counter-rotating the anchor guide during the step of moving the delivery catheter from the first chamber to the second chamber. An entirety of the anchor can be positioned within the second chamber and not the first chamber after the step of moving the delivery catheter from the first chamber to the second chamber.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
Described herein are devices and methods for use in delivering a valve prosthesis, including an anchor and/or frame, for example during a mitral valve replacement.
In some embodiments, the anchor guide 1000 can be formed of a hypotube, such a hypotube having a plurality of slits or cuts 1010 therein (see
In some embodiments, the anchor guide 1000 is configured to couple with, and be actuated by, one or more actuation elements (e.g., pullwires or cables). Actuation of the anchor guide 1000 with the more actuation elements may transition the anchor guide 1000 from a first configuration (e.g., that enables placement of the anchor guide 1000 within the outer sheath 108) to a second configuration (e.g., that is adapted to manipulate and position an anchor within the heart). As shown in
In some embodiments, the anchor guide 1000 may at least partially self-assemble, for example, using a shape memory effect. As used herein, self-assembly is a process in which a component transitions from a first configuration to a second configuration, without external application of force or direction. In some embodiments, the anchor guide 1000 may have a shape set geometry (e.g., via heat treatment) that is an intermediate geometry, e.g., a geometry that is in between the first configuration (e.g., straight) geometry and the second configuration (e.g., fully curved) geometry. The intermediate shape set geometry can reduce strain within the anchor guide 1000, for example, with respect to a strain induced by the first configuration and/or the second configuration geometry. By having an intermediate shape set that is between the first and second configurations, the strain in the anchor guide 1000 can be reduced as it transitions from the first configuration to the second configuration. For example, the anchor guide 1000 may have a (−) 3% strain in a specific region to obtain the first configuration and a (+) 3% strain to obtain the second configuration rather than 6% strain if shape set were at either of the end point configurations. The intermediate shape set geometry can further bias or urge the anchor guide 1000 to transition toward the second configuration from the first configuration as the anchor guide 1000 is deployed. The anchor guide 1000 may be formed of any of the materials described herein—for example, of a shape memory material (e.g., nitinol).
The anchor guide 1000 can include a plurality of sections 1001-1006 that may provide distinct features and/or functions for the anchor guide 1000 (e.g., during deployment of the anchor control catheter 122 and/or of the anchor). The anchor guide 1000 in the first configuration may be substantially straight or elongate (as shown in
Section 1001 can be the proximal-most section and can be configured to bond (e.g., thermally bond) to the distal portion of the anchor control catheter. Section 1001 can further include a plurality of window cuts (see
Section 1002, in turn, can include a plurality of aligned toothed wedge cuts 1010 having substantially equivalent lengths. The bending of section 1002 (towards the cuts) can be controlled by the first actuation element (that terminates at first termination point 1011) while the bending of the rest of the sections 1003-1006 can be controlled by the second actuation element (that terminates at the second termination point 1012). Because the bending of section 1002 is controlled by a separate actuation element from the rest of the sections, the bending section 1002 can be used to alter the planarity of the anchor 114 and/or guide 1000 during delivery of the anchor 114 (e.g., during encircling of the chordae).
Section 1003 can be configured as the inversion section (e.g., can include a u-shaped bend in the second configuration, such as a bend transitioning in direction through 160°-200°, such as 170°-190°, such as approximately 180°). In some embodiments, section 1003 can have an intermediate shapeset to reduce strain and/or to bias the section 1003 towards the desired curvature. Section 1003 can include a plurality of aligned toothed wedge cuts 1010 having substantially equivalent lengths. The toothed wedge cuts 1010 of section 1003 can be circumferentially offset (e.g., by approximately 90 degrees) from the toothed wedge cuts 1010 of section 1002.
Section 1004 can be a substantially straight section having a plurality of interlocking spiral cuts 1010. Section 1004 can be substantially rigid and straight with minimal compression in the second configuration and flexible in the first configuration (e.g., when no force is applied by the actuation element).
Section 1005 in the second configuration can have a twist along a curve that is tangent to the proximal section 1004 and/or to the distal end of section 1006. Section 1005 can include a plurality of toothed wedge cuts 1010 arranged in a spiral pattern and can further include an intermediate shapeset.
Finally, distal section 1006 can be configured to support and guide the anchor during encircling and/or valve deployment. The distal section 1006 in the second configuration can curve substantially in-plane and along the same axis as the anchor. Section 1005 can further include a plurality of aligned toothed wedge cuts 1010 of substantially equal length and can have an intermediate shapeset.
In some embodiments, the anchor guide 1000 can enable delivery of an anchor and a valve using a single catheter delivery system. For example,
Advantageously, the anchor guide 1000 can enable use of a single catheter delivery system 3000 while also ensuring anchor planarity and positioning control. That is, because the anchor guide 1000 can be inverted within the ventricle 104, the valve prosthesis 120 can be positioned radially within, and axially aligned relative to, the anchor 114 while the anchor guide 1000 remains in position. Further, the anchor guide 1000 can be used to specifically and accurately adjust the planarity and position of the anchor 114 both before, during, and after deployment of the prosthetic valve. The anchor guide 1000 can advantageously be relatively flexible in the first (non-actuated) configuration and relatively rigid in the second (actuated) configuration for enhanced control of the anchor 114. The anchor guide 1000 in the second configuration can advantageously both provide support to the anchor 114 during encircling of the anchor 114 and can hold the anchor 114 in the correct location for valve deployment when a single catheter delivery system 3000 is used.
In some embodiments, the anchor guide 1000 can be part of a double catheter delivery system (e.g., a delivery system that includes a catheter for delivery of the anchor and a separate catheter for delivery of the frame). For example,
The anchor guide 1000 can advantageously be relatively flexible in the first (non-actuated) configuration and relatively rigid in the second (actuated) configuration for enhanced control of the anchor 114. Advantageously, the anchor guide 1000 in the second configuration can be used as part of a double catheter delivery system to precisely control placement of the anchor 114 prior to delivery (e.g., as a result of the specific shape and stiffness of the anchor guide 1000 in the second configuration). Further, the anchor guide 1000 in the second configuration can provide support to the anchor during encircling. The bends or curves of the anchor guide 1000 in the second configuration can additionally advantageously be fully inside the ventricle (below the leaflets) during encircling instead of in the intra-annular space, thereby preventing the anchor guide 1000 from interfering with the functioning of the leaflets. Additionally, the anchor guide 1000, because it leaves a tether 118 inverted and concentrically placed within the anchor 114, can advantageously enable concentric delivery of the valve 120 therethrough.
In some embodiments, an inverted anchor guide for use with a single catheter delivery system can be slightly different in configuration and design from an inverted anchor guide for use with a double catheter delivery system. For example, as shown in
Although described herein as being actuated by one or more actuation elements such as pullwires or cables, it should be understood that other actuating mechanisms are possible. For example, a concentric actuation mechanism can be used whereby an inner shaft can be pulled proximally relative to the anchor guide 1000 to transition the anchor guide 1000 from the first configuration to the second configuration (e.g., as described with respect to
Another exemplary anchor guide 2000 is shown in
In some embodiments, the anchor guide 2000 is configured to couple with, and be actuated by, one or more actuation elements (e.g., via a concentric actuation member as described with respect to
In some embodiments, the anchor guide 2000 may at least partially self-assemble, for example, using a shape memory effect. In some embodiments (and as shown in
The anchor guide 2000 can include a plurality of sections 2001-2004 that may provide distinct features and/or functions for the anchor guide 2000 (e.g., during deployment of the anchor control catheter and/or of the anchor). The anchor guide 2000 in the first configuration may be substantially straight or elongate (as shown in
Proximal section 2001 can be the proximal-most section and can be configured to bond (e.g., thermally bond) to the distal portion of the anchor control catheter 122. Section 2001 can be substantially straight and axially aligned with a distal end of the anchor control catheter 122. Sections 2002-2004 can all include a spine, a plurality of window cuts (e.g., to reduce friction with the concentric actuation member), and a plurality of toothed wedge cuts (e.g., trapezoidal cuts) to create hard stops to form the final shape (e.g., the second configuration). The cross-section of section 2003 is shown in
Additionally, each of sections 2002-2004 can have a respective intermediate shape set. Section 2002 can include a plurality of axially aligned cuts and can be configured to curve away axially and radially away from the straight section 2001. Section 2003 can include a plurality of cuts arranged in a spiral pattern such that section 2003 takes on a three-dimensional spiral in the second configuration. Finally, distal section 2004 can include a plurality of axially aligned cuts configured such that section 2004 takes on a flat or planar curve that is concentric with the axis 2005 of section 2001 and that arcs through approximately 150-210 degrees, such as 180 degrees (e.g., so as to hold 180 degrees of the spiral anchor 114 therein). The distal section 2004 can further be positioned within a plane that is perpendicular to the axis 2005 of the proximal section 2001.
In some embodiments, the anchor guide 2000 can be part of a double catheter delivery system (e.g., a delivery system that includes a catheter for delivery of the anchor 114 and a separate catheter for delivery of the valve 120). For example,
Advantageously, as shown in
Referring to
Referring to
Advantageously, the anchor guides 1000/2000 described herein enable the anchor 114 to be positioned concentric to the axis of rotation of the anchor control catheter 122, thereby enabling the anchor to rotate concentrically about the native chordae when the anchor control catheter 122 is rotated.
Although the anchor guides 1000/2000 are described herein as transitioning from the first to the second configuration after exiting the sheath 108 and before deployment of the anchor 114, other sequences of steps are possible. For example, in one method, the anchor 114 may be deployed from the anchor guide 1000/2000 while the anchor guide 1000/2000 is in an intermediate configuration (i.e., between the first and second configurations). For example, the anchor 114 can be deployed from the anchor guide 1000/2000 while it is in an intermediate shape set configuration. The anchor guide 1000/2000 can then be fully transitioned to the second configuration when the anchor 114 has been partially or fully deployed from the anchor guide 1000/2000. Having the anchor 114 deployed from the anchor guide 1000/2000 while the anchor guide 1000/2000 is in the intermediate shape set configuration may advantageously reduce friction on the anchor 114 as the anchor 114 moves through the anchor guide 1000/2000 while also advantageously directing the anchor 114 to wrap around the anchor guide 1000/2000 (e.g., for concentric positioning when the anchor guide 1000/2000 is in the second configuration).
Additional delivery system features are described in International Application No. PCT/US2020/023671, filed on Mar. 19, 2020, titled “PROSTHETIC CARDIAC VALVE DEVICES, SYSTEMS, AND METHODS,” now PCT Publication No. WO 2020/191216 and in International Application No. PCT/US2021/040623, filed on Jul. 7, 2021, titled “VALVE DELIVERY SYSTEM,” the entirety of which is incorporated by reference herein.
The anchor described herein can be a spiral anchor (e.g., a flat spiral anchor). The anchor can be configured to extend around the chordae of the valve (e.g., the mitral valve) and around the valve prosthesis to hold the valve prosthesis in place. Exemplary anchors are described in International Application No. PCT/US2019/068088, filed on Dec. 20, 2019, titled “PROSTHETIC CARDIAC VALVE DEVICES, SYSTEMS, AND METHODS,” now PCT Publication No. WO 2020/132590, the entirety of which is incorporated by reference herein. In some embodiments, the anchor can have a proximal end (e.g., the end configured to engage with the delivery system) that is substantially in the plane of the annulus or is pointed down into the ventricle.
The valve prosthesis described herein can be similar to those of existing transcatheter-delivered valves. The valve prosthesis can be similar to existing surgical tissue valves, and mechanical valves. At least a portion of the valve segment may be positioned within at least a portion of the valve prosthesis, for example with a frame structure of the valve prosthesis. The valve segment may include leaflets formed of multi-layered materials for preferential function. The valve segment may comprise at least one leaflet having an inner layer and an outer layer. The valve segment may be attached directly to the valve prosthesis. Alternatively, the valve segment may be attached to an intermediate valve structure that is in turn connected to the valve prosthesis. The valve segment may be connected to the valve prosthesis before or after the valve prosthesis has been deployed adjacent a native valve. The valve prosthesis may be attached to a leaflet of the valve segment, for example an outer layer of a leaflet, at one or more ends of the valve prosthesis. The valve prosthesis may be attached to a leaflet of the valve segment, for example an outer layer of a leaflet, at one or more intermediate portions of the valve prosthesis. The valve segment may comprise a plurality of leaflets. The valve segment may comprise a biocompatible one-way valve. Flow in one direction may cause the leaflet(s) to deflect open and flow in the opposite direction may cause the leaflet(s) to close.
The frame structure may be configured like a stent. The frame structure may, for example, comprise a scaffold in a diamond pattern formed from a shape memory material (e.g., nitinol, NiTi). One of ordinary skill in the art will appreciate that many other structures, materials, and configurations may be employed for the frame structure. For example, the frame structure may be formed of a polymer of sufficient elasticity. The frame structure may be formed of a combination of metal and polymer, such as metal (e.g., shape memory material) covered in polymer. The frame structure may include a variety of patterns besides diamond shapes. In some embodiments, the frame structure is a closed frame such that blood flow is forced through valve segment therein. One or more skirts and/or seals may help force blood through the valve segment. Exemplary frame structures and valve prostheses are described in International Application No. PCT/US2020/027744, filed on Apr. 10, 2020, titled “MINIMAL FRAME PROSTHETIC CARDIAC VALVE DELIVERY DEVICES, SYSTEMS, AND METHODS,” now PCT Publication No. WO 2020/210685, the entirety of which is incorporated by reference herein.
One of ordinary skill in the art will recognize based on the description herein that any of the valve prostheses described herein may comprise any of the frame structure shapes, frame structure designs, frame structure materials, anchor shapes, anchor windings, anchor materials, free end tips, leaflet(s) configurations, or any other of the variable features described herein in any combination thereof as desired.
It should be understood that any feature described herein with respect to one embodiment may be combined with or substituted for any feature described with respect to another embodiment.
When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected,” “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected,” “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a,” “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.
Spatially relative terms, such as “under,” “below,” “lower,” “over,” “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly,” “downwardly,” “vertical,” “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
Although the terms “first” and “second” may be used herein to describe various features/elements (including steps), these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word “comprise,” and variations such as “comprises” and “comprising” means various components can be co-jointly employed in the methods and articles (e.g., compositions and apparatuses including device and methods). For example, the term “comprising” will be understood to imply the inclusion of any stated elements or steps but not the exclusion of any other elements or steps.
As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), or +/−10% of the stated value (or range of values). Any numerical values given herein should also be understood to include about or approximately that value, unless the context indicates otherwise. For example, if the value “10” is disclosed, then “about 10” is also disclosed. Any numerical range recited herein is intended to include all sub-ranges subsumed therein. It is also understood that when a value is disclosed that “less than or equal to” the value, “greater than or equal to the value” and possible ranges between values are also disclosed, as appropriately understood by the skilled artisan. For example, if the value “X” is disclosed the “less than or equal to X” as well as “greater than or equal to X” (e.g., where X is a numerical value) is also disclosed. It is also understood that the throughout the application, data is provided in a number of different formats, and that these data represent endpoints and starting points, and ranges for any combination of the data points. For example, if a particular data point “10” and a particular data point “15” are disclosed, it is understood that greater than, greater than or equal to, less than, less than or equal to, and equal to 10 and 15 are considered disclosed as well as between 10 and 15. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.
Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.
The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
This application claims priority to U.S. Provisional Patent Application No. 63/072,788, filed on Aug. 31, 2020, titled “VALVE DELIVERY SYSTEM,” the entirety of which is incorporated by reference herein.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/048472 | 8/31/2021 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2022/047393 | 3/3/2022 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4725274 | Lane et al. | Feb 1988 | A |
5002563 | Pyka et al. | Mar 1991 | A |
5327905 | Avitall | Jul 1994 | A |
5356424 | Buzerak et al. | Oct 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5582616 | Bolduc et al. | Dec 1996 | A |
5755601 | Jones | May 1998 | A |
5779669 | Haissaguerre et al. | Jul 1998 | A |
5873835 | Hastings et al. | Feb 1999 | A |
5944690 | Falwell et al. | Aug 1999 | A |
5997526 | Giba et al. | Dec 1999 | A |
6048339 | Zirps et al. | Apr 2000 | A |
6053873 | Govari et al. | Apr 2000 | A |
6254550 | McNamara et al. | Jul 2001 | B1 |
6419695 | Gabbay | Jul 2002 | B1 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6530952 | Vesely | Mar 2003 | B2 |
6533783 | Töllner | Mar 2003 | B1 |
6641553 | Chee et al. | Nov 2003 | B1 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6908478 | Alferness et al. | Jun 2005 | B2 |
6964684 | Ortiz et al. | Nov 2005 | B2 |
6974476 | McGuckin, Jr. et al. | Dec 2005 | B2 |
7077861 | Spence | Jul 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7160322 | Gabbay | Jan 2007 | B2 |
7175656 | Khairkhahan | Feb 2007 | B2 |
7201771 | Lane | Apr 2007 | B2 |
7226467 | Lucatero et al. | Jun 2007 | B2 |
7381219 | Salahieh et al. | Jan 2008 | B2 |
7329279 | Haug et al. | Feb 2008 | B2 |
7445631 | Salahieh et al. | Nov 2008 | B2 |
7470285 | Nugent et al. | Dec 2008 | B2 |
7527647 | Spence | May 2009 | B2 |
7534261 | Freidman | May 2009 | B2 |
7563267 | Goldfarb et al. | Jul 2009 | B2 |
7594903 | Webler et al. | Sep 2009 | B2 |
7604646 | Goldfarb et al. | Oct 2009 | B2 |
7608091 | Goldfarb et al. | Oct 2009 | B2 |
7618449 | Tremulis et al. | Nov 2009 | B2 |
7621948 | Herrmann et al. | Nov 2009 | B2 |
7666204 | Thornton et al. | Feb 2010 | B2 |
7704269 | St. Goar et al. | Apr 2010 | B2 |
7731705 | Wardle | Jun 2010 | B2 |
7748389 | Salahich et al. | Jul 2010 | B2 |
7749266 | Forster et al. | Jul 2010 | B2 |
7780725 | Haug et al. | Aug 2010 | B2 |
7799069 | Bailey et al. | Sep 2010 | B2 |
7811296 | Goldfarb et al. | Oct 2010 | B2 |
7824442 | Salahieh et al. | Nov 2010 | B2 |
7824443 | Salahieh et al. | Nov 2010 | B2 |
7846203 | Cribier | Dec 2010 | B2 |
7947075 | Goetz et al. | May 2011 | B2 |
7951195 | Antonsson et al. | May 2011 | B2 |
7959666 | Salahleh et al. | Jun 2011 | B2 |
7988724 | Salahieh et al. | Aug 2011 | B2 |
8021421 | Fogarty et al. | Sep 2011 | B2 |
8052749 | Salahieh et al. | Nov 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8070800 | Lock et al. | Dec 2011 | B2 |
8075615 | Eberhardt et al. | Dec 2011 | B2 |
8096985 | Legaspi et al. | Jan 2012 | B2 |
8147541 | Forster et al. | Apr 2012 | B2 |
8147542 | Maisano et al. | Apr 2012 | B2 |
8182528 | Salahieh et al. | May 2012 | B2 |
8216256 | Raschdorf et al. | Jul 2012 | B2 |
8236049 | Rowe et al. | Aug 2012 | B2 |
8241351 | Cabiri | Aug 2012 | B2 |
8251977 | Partlett | Aug 2012 | B2 |
8252050 | Maisano et al. | Aug 2012 | B2 |
8287584 | Salahleh et al. | Oct 2012 | B2 |
8313526 | Hoffman et al. | Nov 2012 | B2 |
8323241 | Salahleh et al. | Dec 2012 | B2 |
8323336 | Hill et al. | Dec 2012 | B2 |
8328868 | Paul et al. | Dec 2012 | B2 |
8343213 | Salahieh et al. | Jan 2013 | B2 |
8348995 | Tuval et al. | Jan 2013 | B2 |
8348996 | Tuval et al. | Jan 2013 | B2 |
8366767 | Zhang | Feb 2013 | B2 |
8403981 | Forster et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8414643 | Tuval et al. | Apr 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8414645 | Dwork et al. | Apr 2013 | B2 |
8425593 | Braido et al. | Apr 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8454686 | Alkhatib | Jun 2013 | B2 |
8465541 | Dwork | Jun 2013 | B2 |
8500800 | Maisano et al. | Aug 2013 | B2 |
8512401 | Murray et al. | Aug 2013 | B2 |
8523881 | Cabiri et al. | Sep 2013 | B2 |
8545553 | Zipory et al. | Oct 2013 | B2 |
8556963 | Tremulis et al. | Oct 2013 | B2 |
8562645 | Stone et al. | Oct 2013 | B2 |
8562673 | Yeung et al. | Oct 2013 | B2 |
8579962 | Salahieh et al. | Nov 2013 | B2 |
8603157 | Seguin et al. | Dec 2013 | B2 |
8603160 | Salahieh et al. | Dec 2013 | B2 |
8623075 | Murray et al. | Jan 2014 | B2 |
8628570 | Seguin | Jan 2014 | B2 |
8641727 | Starksen et al. | Feb 2014 | B2 |
8652202 | Alon et al. | Feb 2014 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8657872 | Seguin | Feb 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8696693 | Najafi et al. | Apr 2014 | B2 |
8715342 | Zipory et al. | May 2014 | B2 |
8740976 | Tran et al. | Jun 2014 | B2 |
8784479 | Antonsson et al. | Jul 2014 | B2 |
8790367 | Nguyen et al. | Jul 2014 | B2 |
8808368 | Maisano et al. | Aug 2014 | B2 |
8828078 | Salahich et al. | Sep 2014 | B2 |
8834564 | Tuval et al. | Sep 2014 | B2 |
8840663 | Salahieh et al. | Sep 2014 | B2 |
8840664 | Karapetian et al. | Sep 2014 | B2 |
8845588 | Bruszewski | Sep 2014 | B2 |
8852271 | Murray et al. | Oct 2014 | B2 |
8876893 | Dwork et al. | Nov 2014 | B2 |
8876894 | Tuval et al. | Nov 2014 | B2 |
8876895 | Tuval et al. | Nov 2014 | B2 |
8900294 | Paniagua et al. | Dec 2014 | B2 |
8911494 | Hammer et al. | Dec 2014 | B2 |
8920369 | Salahieh et al. | Dec 2014 | B2 |
8926690 | Kowalsky | Jan 2015 | B2 |
8926696 | Cabiri et al. | Jan 2015 | B2 |
8926697 | Gross et al. | Jan 2015 | B2 |
8940002 | Goertzen | Jan 2015 | B2 |
8940044 | Hammer et al. | Jan 2015 | B2 |
8951299 | Paul et al. | Feb 2015 | B2 |
8986371 | Quill et al. | Mar 2015 | B2 |
8998980 | Shipley et al. | Apr 2015 | B2 |
9005273 | Salahleh et al. | Apr 2015 | B2 |
9011515 | Schweich et al. | Apr 2015 | B2 |
9011523 | Seguin | Apr 2015 | B2 |
9011530 | Reich et al. | Apr 2015 | B2 |
9017408 | Siegal et al. | Apr 2015 | B2 |
9023100 | Quadri et al. | May 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9039757 | McLean et al. | May 2015 | B2 |
9056009 | Keränen | Jun 2015 | B2 |
9061120 | Osypka et al. | Jun 2015 | B2 |
9095431 | Yu et al. | Aug 2015 | B2 |
9119719 | Zipory et al. | Sep 2015 | B2 |
9125739 | Paniagua et al. | Sep 2015 | B2 |
9125740 | Morriss et al. | Sep 2015 | B2 |
9155619 | Liu et al. | Oct 2015 | B2 |
9168129 | Valdez et al. | Oct 2015 | B2 |
9168131 | Yohanan et al. | Oct 2015 | B2 |
9173713 | Hart et al. | Nov 2015 | B2 |
9173737 | Hill et al. | Nov 2015 | B2 |
9180006 | Keränen | Nov 2015 | B2 |
9226823 | Dwork | Jan 2016 | B2 |
9232995 | Kovalsky et al. | Jan 2016 | B2 |
9277994 | Miller et al. | Mar 2016 | B2 |
9289297 | Wilson et al. | Mar 2016 | B2 |
9295547 | Costello et al. | Mar 2016 | B2 |
9301756 | Wardle | Apr 2016 | B2 |
9301836 | Buchbinder et al. | Apr 2016 | B2 |
9320597 | Savage et al. | Apr 2016 | B2 |
9343224 | Zilbershlag | May 2016 | B2 |
9358110 | Paul et al. | Jun 2016 | B2 |
9414915 | Lombardi et al. | Aug 2016 | B2 |
9427315 | Schweich et al. | Aug 2016 | B2 |
9439757 | Wallace et al. | Sep 2016 | B2 |
9468525 | Kovalsky | Oct 2016 | B2 |
9474606 | Zipory et al. | Oct 2016 | B2 |
9474840 | Siess | Oct 2016 | B2 |
9480559 | Vidlund et al. | Nov 2016 | B2 |
9492273 | Wallace et al. | Nov 2016 | B2 |
9526487 | Rahmani | Dec 2016 | B2 |
9526609 | Salahieh et al. | Dec 2016 | B2 |
9532868 | Braido | Jan 2017 | B2 |
9532870 | Cooper et al. | Jan 2017 | B2 |
9561102 | Rust et al. | Feb 2017 | B2 |
9579198 | Deem et al. | Feb 2017 | B2 |
9636224 | Zipory et al. | May 2017 | B2 |
9636481 | Campbell et al. | May 2017 | B2 |
9662202 | Quill et al. | May 2017 | B2 |
9662206 | Börtlein et al. | May 2017 | B2 |
9662209 | Gross et al. | May 2017 | B2 |
9675454 | Vidlund et al. | Jun 2017 | B2 |
9681952 | Hacohen et al. | Jun 2017 | B2 |
9687343 | Börtlein et al. | Jun 2017 | B2 |
9724192 | Sheps et al. | Aug 2017 | B2 |
9730790 | Quadri et al. | Aug 2017 | B2 |
9730793 | Reich et al. | Aug 2017 | B2 |
9744031 | Girard et al. | Aug 2017 | B2 |
9744038 | Dahlgren et al. | Aug 2017 | B2 |
9750605 | Ganesan et al. | Sep 2017 | B2 |
9763779 | Börtlein et al. | Sep 2017 | B2 |
9763780 | Morriss et al. | Sep 2017 | B2 |
9814611 | Cartledge et al. | Nov 2017 | B2 |
9827090 | Hill et al. | Nov 2017 | B2 |
9861480 | Zakai et al. | Jan 2018 | B2 |
9867700 | Bakis et al. | Jan 2018 | B2 |
9867702 | Keränen et al. | Jan 2018 | B2 |
9877833 | Bishop et al. | Jan 2018 | B1 |
9883941 | Hastings et al. | Feb 2018 | B2 |
9889003 | Börtlein et al. | Feb 2018 | B2 |
9895221 | Vidlund | Feb 2018 | B2 |
9895222 | Zeng et al. | Feb 2018 | B2 |
9901444 | Valdez et al. | Feb 2018 | B2 |
9918840 | Reich et al. | Mar 2018 | B2 |
D815744 | Ratz et al. | Apr 2018 | S |
9949825 | Braido et al. | Apr 2018 | B2 |
9949828 | Sheps et al. | Apr 2018 | B2 |
9950142 | Eversull et al. | Apr 2018 | B2 |
9968452 | Sheps et al. | May 2018 | B2 |
9974647 | Ganesan et al. | May 2018 | B2 |
9974650 | Nguyen-Thien-Nhon et al. | May 2018 | B2 |
9999504 | Czyscon et al. | Jun 2018 | B2 |
10004599 | Rabito et al. | Jun 2018 | B2 |
10016271 | Morriss et al. | Jul 2018 | B2 |
10016272 | Spence et al. | Jul 2018 | B2 |
10028832 | Quill et al. | Jul 2018 | B2 |
10029037 | Muller et al. | Jul 2018 | B2 |
10034747 | Harewood | Jul 2018 | B2 |
10034749 | Spence et al. | Jul 2018 | B2 |
10039637 | Maimon et al. | Aug 2018 | B2 |
10045846 | Bonyuet et al. | Aug 2018 | B2 |
10052198 | Chau et al. | Aug 2018 | B2 |
10052199 | Spence et al. | Aug 2018 | B2 |
10058318 | Tegzes | Aug 2018 | B2 |
10058321 | Sampson et al. | Aug 2018 | B2 |
10064719 | Börtlein et al. | Sep 2018 | B2 |
10070954 | Braido et al. | Sep 2018 | B2 |
10092400 | Jimenez et al. | Oct 2018 | B2 |
10098734 | Hoang | Oct 2018 | B2 |
10105217 | Keränen | Oct 2018 | B2 |
10105224 | Buchbinder et al. | Oct 2018 | B2 |
10130464 | Meiri et al. | Nov 2018 | B2 |
10130471 | Keränen et al. | Nov 2018 | B2 |
10143552 | Wallace et al. | Dec 2018 | B2 |
10149759 | Naor | Dec 2018 | B2 |
10172708 | Anderson | Jan 2019 | B2 |
10172711 | Keränen | Jan 2019 | B2 |
10179042 | Braido et al. | Jan 2019 | B2 |
10195021 | Keränen et al. | Feb 2019 | B2 |
10195025 | Levi et al. | Feb 2019 | B2 |
10195027 | Nasr | Feb 2019 | B2 |
10195028 | Hosmer et al. | Feb 2019 | B2 |
10195029 | Keränen | Feb 2019 | B2 |
10201418 | Biadillah et al. | Feb 2019 | B2 |
10206775 | Kovalsky et al. | Feb 2019 | B2 |
10213307 | Dwork et al. | Feb 2019 | B2 |
10226330 | Spence et al. | Mar 2019 | B2 |
10226334 | Rowe et al. | Mar 2019 | B2 |
10238489 | Conklin | Mar 2019 | B2 |
10251749 | Zerkowski et al. | Apr 2019 | B2 |
10258464 | Delaloye et al. | Apr 2019 | B2 |
10258468 | Deem et al. | Apr 2019 | B2 |
10265169 | Desrosiers et al. | Apr 2019 | B2 |
10271950 | Neustadter | Apr 2019 | B2 |
10299917 | Morriss et al. | May 2019 | B2 |
10299921 | Dale et al. | May 2019 | B2 |
10314701 | Von Segesser et al. | Jun 2019 | B2 |
10321988 | Gorman et al. | Jun 2019 | B2 |
10321989 | Keränen | Jun 2019 | B2 |
10327743 | St. Goar et al. | Jun 2019 | B2 |
10327766 | Zerkowski et al. | Jun 2019 | B2 |
10335277 | Crisostomo et al. | Jul 2019 | B2 |
10338724 | Zhao | Jul 2019 | B2 |
10350066 | Cooper et al. | Jul 2019 | B2 |
10357351 | Cooper et al. | Jul 2019 | B2 |
10357634 | Simmons et al. | Jul 2019 | B2 |
10363130 | Armer et al. | Jul 2019 | B2 |
10363131 | Eidenschink et al. | Jul 2019 | B2 |
10368986 | Gosal et al. | Aug 2019 | B2 |
10368990 | Noe et al. | Aug 2019 | B2 |
10376266 | Herman et al. | Aug 2019 | B2 |
10376360 | Bruchman et al. | Aug 2019 | B2 |
10376363 | Quadri et al. | Aug 2019 | B2 |
10398547 | Li et al. | Sep 2019 | B2 |
10426608 | Salahieh et al. | Oct 2019 | B2 |
10433961 | McLean | Oct 2019 | B2 |
10470881 | Noe et al. | Nov 2019 | B2 |
10478291 | Nguyen et al. | Nov 2019 | B2 |
10500048 | Khairkhahan et al. | Dec 2019 | B2 |
10507104 | Zhang et al. | Dec 2019 | B2 |
10512541 | Zerkowski et al. | Dec 2019 | B2 |
10524901 | Quadri et al. | Jan 2020 | B2 |
10548729 | Zipory et al. | Feb 2020 | B2 |
10568737 | Noe et al. | Feb 2020 | B2 |
10575951 | Johnson et al. | Mar 2020 | B2 |
10603165 | Maimon et al. | Mar 2020 | B2 |
10639154 | Seguin | May 2020 | B2 |
10653524 | Khairkhahan et al. | May 2020 | B2 |
10660753 | Pham et al. | May 2020 | B2 |
10687938 | Patel et al. | Jun 2020 | B2 |
10695160 | Lashinski et al. | Jun 2020 | B2 |
10702386 | Khairkhahan et al. | Jul 2020 | B2 |
10709552 | Backus et al. | Jul 2020 | B2 |
10716662 | Delaloye et al. | Jul 2020 | B2 |
10722352 | Spence | Jul 2020 | B2 |
10722353 | Levi | Jul 2020 | B2 |
10729542 | Howard et al. | Aug 2020 | B2 |
10743991 | Brown | Aug 2020 | B2 |
10751180 | Schewel | Aug 2020 | B2 |
10751184 | Reich et al. | Aug 2020 | B2 |
10765514 | Iflah et al. | Sep 2020 | B2 |
10813749 | Nguyen et al. | Oct 2020 | B2 |
10828153 | Noe et al. | Nov 2020 | B2 |
10856970 | Tuval et al. | Dec 2020 | B2 |
10869755 | Granada et al. | Dec 2020 | B2 |
10888420 | Bateman et al. | Jan 2021 | B2 |
10912644 | Argento et al. | Feb 2021 | B2 |
10973629 | Levi et al. | Apr 2021 | B2 |
10973630 | Torrianni et al. | Apr 2021 | B2 |
11007057 | Pham et al. | May 2021 | B2 |
11020221 | Arcaro et al. | Jun 2021 | B2 |
11039922 | Konno | Jun 2021 | B2 |
11471282 | Argento et al. | Oct 2022 | B2 |
11672657 | Argento et al. | Jun 2023 | B2 |
20020173841 | Ortiz et al. | Nov 2002 | A1 |
20030114913 | Spenser et al. | Jun 2003 | A1 |
20030233142 | Morales et al. | Dec 2003 | A1 |
20040039442 | St. Goar et al. | Feb 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137687 | Salahich et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137694 | Haug et al. | Jun 2005 | A1 |
20050137696 | Salahleh et al. | Jun 2005 | A1 |
20050165344 | Dobak, III | Jul 2005 | A1 |
20050240202 | Shennib et al. | Oct 2005 | A1 |
20050277839 | Alderman et al. | Dec 2005 | A1 |
20060009841 | McGuckin, Jr. et al. | Jan 2006 | A1 |
20060052821 | Abbot et al. | Mar 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060178700 | Quinn | Aug 2006 | A1 |
20060217762 | Maahs et al. | Sep 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060293698 | Douk | Dec 2006 | A1 |
20070051377 | Douk et al. | Mar 2007 | A1 |
20070055206 | To et al. | Mar 2007 | A1 |
20070118151 | Davidson | May 2007 | A1 |
20070142907 | Moaddeb et al. | Jun 2007 | A1 |
20070185572 | Solem et al. | Aug 2007 | A1 |
20070255396 | Douk et al. | Nov 2007 | A1 |
20070293724 | Saadat et al. | Dec 2007 | A1 |
20070293943 | Quinn | Dec 2007 | A1 |
20080004696 | Vesely | Jan 2008 | A1 |
20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
20080200980 | Robin et al. | Aug 2008 | A1 |
20080208327 | Rowe | Aug 2008 | A1 |
20080275503 | Spence et al. | Nov 2008 | A1 |
20080275540 | Wen | Nov 2008 | A1 |
20090093826 | Warder-Gabaldon | Apr 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090192601 | Rafiee et al. | Jul 2009 | A1 |
20090209950 | Starksen | Aug 2009 | A1 |
20090222026 | Rothstein et al. | Sep 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20100010520 | Takahashi et al. | Jan 2010 | A1 |
20100049239 | McGuckin, Jr. et al. | Feb 2010 | A1 |
20100076497 | Zwirkoski | Mar 2010 | A1 |
20100094406 | Leprince et al. | Apr 2010 | A1 |
20100185172 | Fabro | Jul 2010 | A1 |
20100198056 | Fabro et al. | Aug 2010 | A1 |
20100198192 | Serina et al. | Aug 2010 | A1 |
20100198208 | Napp et al. | Aug 2010 | A1 |
20100217385 | Thompson et al. | Aug 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20110022164 | Quinn et al. | Jan 2011 | A1 |
20110046600 | Crank | Feb 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110288637 | De Marchena | Nov 2011 | A1 |
20110313515 | Quadri et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120022633 | Olson et al. | Jan 2012 | A1 |
20120053680 | Bolling et al. | Mar 2012 | A1 |
20120143316 | Seguin et al. | Jun 2012 | A1 |
20120197388 | Khairkhahan et al. | Aug 2012 | A1 |
20120203333 | McGuckin, Jr. et al. | Aug 2012 | A1 |
20120221101 | Moaddeb et al. | Aug 2012 | A1 |
20120277853 | Rothstein | Nov 2012 | A1 |
20130006352 | Yaron | Jan 2013 | A1 |
20130023985 | Khairkhahan et al. | Jan 2013 | A1 |
20130035758 | Seguin et al. | Feb 2013 | A1 |
20130079873 | Migliazza et al. | Mar 2013 | A1 |
20130123912 | Tung et al. | May 2013 | A1 |
20130172992 | Gross et al. | Jul 2013 | A1 |
20130253643 | Rolando et al. | Sep 2013 | A1 |
20130274873 | Delaloye et al. | Oct 2013 | A1 |
20130325110 | Khalil et al. | Dec 2013 | A1 |
20140005768 | Thomas et al. | Jan 2014 | A1 |
20140031928 | Murphy et al. | Jan 2014 | A1 |
20140081154 | Toth | May 2014 | A1 |
20140200649 | Essinger et al. | Jul 2014 | A1 |
20140228943 | Stigall et al. | Aug 2014 | A1 |
20140249621 | Eidenschink | Sep 2014 | A1 |
20140257467 | Lane et al. | Sep 2014 | A1 |
20140277382 | Dolan et al. | Sep 2014 | A1 |
20140277409 | Börtlein et al. | Sep 2014 | A1 |
20140324163 | Keränen et al. | Oct 2014 | A1 |
20140379074 | Spence et al. | Dec 2014 | A1 |
20150005764 | Hanson et al. | Jan 2015 | A1 |
20150018876 | Ewers et al. | Jan 2015 | A1 |
20150051709 | Vasquez et al. | Feb 2015 | A1 |
20150134055 | Spence et al. | May 2015 | A1 |
20150173897 | Raanani et al. | Jun 2015 | A1 |
20150250480 | Featherstone | Sep 2015 | A1 |
20150265403 | Keränen | Sep 2015 | A1 |
20150272737 | Dale et al. | Oct 2015 | A1 |
20150297346 | Duffy et al. | Oct 2015 | A1 |
20150305863 | Gray et al. | Oct 2015 | A1 |
20150328000 | Ratz et al. | Nov 2015 | A1 |
20150335290 | Hunter | Nov 2015 | A1 |
20150351735 | Keränen et al. | Dec 2015 | A1 |
20150351908 | Keränen et al. | Dec 2015 | A1 |
20150351911 | Keränen et al. | Dec 2015 | A1 |
20160089126 | Guo | Mar 2016 | A1 |
20160095705 | Keränen et al. | Apr 2016 | A1 |
20160113764 | Sheahan et al. | Apr 2016 | A1 |
20160143689 | Ditter | May 2016 | A1 |
20160143731 | Backus et al. | May 2016 | A1 |
20160166380 | Seguin et al. | Jun 2016 | A1 |
20160206853 | Bolduc | Jul 2016 | A1 |
20160228247 | Maimon et al. | Aug 2016 | A1 |
20160235526 | Lashinski et al. | Aug 2016 | A1 |
20160235529 | Ma et al. | Aug 2016 | A1 |
20160324637 | Hlavka et al. | Nov 2016 | A1 |
20160324639 | Nguyen et al. | Nov 2016 | A1 |
20160331523 | Chau et al. | Nov 2016 | A1 |
20160346080 | Righini et al. | Dec 2016 | A1 |
20170056163 | Tayeb et al. | Mar 2017 | A1 |
20170071732 | Conklin et al. | Mar 2017 | A1 |
20170079790 | Vidlund et al. | Mar 2017 | A1 |
20170112624 | Patel | Apr 2017 | A1 |
20170119524 | Salahieh et al. | May 2017 | A1 |
20170128203 | Zhang et al. | May 2017 | A1 |
20170156723 | Keating et al. | Jun 2017 | A1 |
20170165057 | Morriss et al. | Jun 2017 | A9 |
20170189177 | Schweich et al. | Jul 2017 | A1 |
20170216025 | Nitzan et al. | Aug 2017 | A1 |
20170245850 | Call et al. | Aug 2017 | A1 |
20170258585 | Marquez et al. | Sep 2017 | A1 |
20170273788 | O'Carroll et al. | Sep 2017 | A1 |
20170273789 | Yaron et al. | Sep 2017 | A1 |
20170281341 | Lim et al. | Oct 2017 | A1 |
20170311937 | Bambury et al. | Nov 2017 | A1 |
20170348099 | Mendelson et al. | Dec 2017 | A1 |
20180049873 | Manash et al. | Feb 2018 | A1 |
20180055628 | Patel et al. | Mar 2018 | A1 |
20180092763 | Dagan et al. | Apr 2018 | A1 |
20180110622 | Gregg et al. | Apr 2018 | A1 |
20180116790 | Ratz et al. | May 2018 | A1 |
20180133003 | Levi | May 2018 | A1 |
20180177592 | Benichou et al. | Jun 2018 | A1 |
20180177594 | Patel et al. | Jun 2018 | A1 |
20180206982 | Haivatov et al. | Jul 2018 | A1 |
20180206986 | Noe et al. | Jul 2018 | A1 |
20180206992 | Brown | Jul 2018 | A1 |
20180207395 | Bulman et al. | Jul 2018 | A1 |
20180214267 | Lally et al. | Aug 2018 | A1 |
20180214270 | Subramanian et al. | Aug 2018 | A1 |
20180221014 | Darabian | Aug 2018 | A1 |
20180228608 | Sheps et al. | Aug 2018 | A1 |
20180228610 | Lashinski et al. | Aug 2018 | A1 |
20180235443 | Smith et al. | Aug 2018 | A1 |
20180250126 | O'Connor et al. | Sep 2018 | A1 |
20180250132 | Ketai et al. | Sep 2018 | A1 |
20180263764 | Manash et al. | Sep 2018 | A1 |
20180289473 | Rajagopal et al. | Oct 2018 | A1 |
20180289474 | Rajagopal et al. | Oct 2018 | A1 |
20180289478 | Quill | Oct 2018 | A1 |
20180289480 | D'ambra et al. | Oct 2018 | A1 |
20180289485 | Rajagopal et al. | Oct 2018 | A1 |
20180296335 | Miyashiro | Oct 2018 | A1 |
20180296338 | Rabito et al. | Oct 2018 | A1 |
20180318079 | Patel | Nov 2018 | A1 |
20180325665 | Gurovich et al. | Nov 2018 | A1 |
20180333259 | Dibie | Nov 2018 | A1 |
20180344303 | Bambury et al. | Dec 2018 | A1 |
20180344454 | Mauch et al. | Dec 2018 | A1 |
20180344459 | Spence et al. | Dec 2018 | A1 |
20180360600 | Zhuang et al. | Dec 2018 | A1 |
20180368830 | O'Carroll et al. | Dec 2018 | A1 |
20190000615 | Tayeb et al. | Jan 2019 | A1 |
20190000625 | O'Carroll et al. | Jan 2019 | A1 |
20190008635 | Francis et al. | Jan 2019 | A1 |
20190008639 | Landon et al. | Jan 2019 | A1 |
20190008640 | Cooper et al. | Jan 2019 | A1 |
20190015205 | Rajagopal et al. | Jan 2019 | A1 |
20190021859 | O'Carrol et al. | Jan 2019 | A1 |
20190046315 | Gao et al. | Feb 2019 | A1 |
20190053894 | Levi et al. | Feb 2019 | A1 |
20190053895 | Levi | Feb 2019 | A1 |
20190053898 | Maimon et al. | Feb 2019 | A1 |
20190053899 | Levi | Feb 2019 | A1 |
20190053903 | Rohl et al. | Feb 2019 | A1 |
20190060068 | Cope et al. | Feb 2019 | A1 |
20190060069 | Maimon et al. | Feb 2019 | A1 |
20190060071 | Lane et al. | Feb 2019 | A1 |
20190076244 | Yohanan et al. | Mar 2019 | A1 |
20190076664 | Ollivier | Mar 2019 | A1 |
20190117392 | Quadri et al. | Apr 2019 | A1 |
20190133756 | Zhang et al. | May 2019 | A1 |
20190133757 | Zhang et al. | May 2019 | A1 |
20190142589 | Basude | May 2019 | A1 |
20190159770 | Rohl et al. | May 2019 | A1 |
20190160292 | Peichel et al. | May 2019 | A1 |
20190167425 | Reich et al. | Jun 2019 | A1 |
20190183649 | Allen et al. | Jun 2019 | A1 |
20190192296 | Schwartz et al. | Jun 2019 | A1 |
20190201191 | McLean et al. | Jul 2019 | A1 |
20190209311 | Zhang et al. | Jul 2019 | A1 |
20190209312 | Zhang et al. | Jul 2019 | A1 |
20190209313 | Zhang et al. | Jul 2019 | A1 |
20190209314 | Zhang et al. | Jul 2019 | A1 |
20190209315 | Zhang et al. | Jul 2019 | A1 |
20190209316 | Zhang et al. | Jul 2019 | A1 |
20190209317 | Zhang et al. | Jul 2019 | A1 |
20190209318 | Zhang et al. | Jul 2019 | A1 |
20190209320 | Draster et al. | Jul 2019 | A1 |
20190231520 | Desrosiers et al. | Aug 2019 | A1 |
20190240023 | Spence et al. | Aug 2019 | A1 |
20190246916 | Kuraguntla et al. | Aug 2019 | A1 |
20190254816 | Anderson et al. | Aug 2019 | A1 |
20190261995 | Goldfarb et al. | Aug 2019 | A1 |
20190261996 | Goldfarb et al. | Aug 2019 | A1 |
20190261997 | Goldfarb et al. | Aug 2019 | A1 |
20190262129 | Cooper et al. | Aug 2019 | A1 |
20190282237 | Goldfarb et al. | Sep 2019 | A1 |
20190328518 | Neumann | Oct 2019 | A1 |
20190336282 | Christianson et al. | Nov 2019 | A1 |
20190343625 | Gharib et al. | Nov 2019 | A1 |
20190365530 | Hoang et al. | Dec 2019 | A1 |
20190374337 | Zamani et al. | Dec 2019 | A1 |
20190374342 | Gregg et al. | Dec 2019 | A1 |
20200000579 | Manash et al. | Jan 2020 | A1 |
20200000586 | Tian et al. | Jan 2020 | A1 |
20200008936 | Cheema et al. | Jan 2020 | A1 |
20200022811 | Griswold et al. | Jan 2020 | A1 |
20200054453 | Zerkowski et al. | Feb 2020 | A1 |
20200060813 | Nguyen et al. | Feb 2020 | A1 |
20200060820 | Ben-Zvi et al. | Feb 2020 | A1 |
20200060852 | Argento et al. | Feb 2020 | A1 |
20200078000 | Rajagopal et al. | Mar 2020 | A1 |
20200093601 | Neustadter | Mar 2020 | A1 |
20200107932 | Rabito | Apr 2020 | A1 |
20200107933 | Oba | Apr 2020 | A1 |
20200113586 | Karasic et al. | Apr 2020 | A1 |
20200113685 | Miller et al. | Apr 2020 | A1 |
20200113696 | Ekvall et al. | Apr 2020 | A1 |
20200138575 | Tuval | May 2020 | A1 |
20200139082 | Matlock | May 2020 | A1 |
20200178977 | Coleman et al. | Jun 2020 | A1 |
20200188107 | Gloss et al. | Jun 2020 | A1 |
20200205800 | Gilmore et al. | Jul 2020 | A1 |
20200205969 | Hacohen | Jul 2020 | A1 |
20200205974 | Zerkowski et al. | Jul 2020 | A1 |
20200205975 | Khairkhahan | Jul 2020 | A1 |
20200205979 | O'Carroll et al. | Jul 2020 | A1 |
20200214708 | Sharma | Jul 2020 | A1 |
20200229806 | Goldfarb et al. | Jul 2020 | A1 |
20200229918 | Pham et al. | Jul 2020 | A1 |
20200261220 | Argento et al. | Aug 2020 | A1 |
20200275921 | Gilmore et al. | Sep 2020 | A1 |
20200276017 | Subramanian et al. | Sep 2020 | A1 |
20200297489 | Bishop et al. | Sep 2020 | A1 |
20200352705 | Heneghan et al. | Nov 2020 | A1 |
20200352706 | Campbell | Nov 2020 | A1 |
20200360139 | Hammer et al. | Nov 2020 | A1 |
20210022854 | Zhao et al. | Jan 2021 | A1 |
20210022860 | Lally et al. | Jan 2021 | A1 |
20210030536 | Kaleta | Feb 2021 | A1 |
20210121289 | Bruchman et al. | Apr 2021 | A1 |
20210128297 | Braido et al. | May 2021 | A1 |
20210145573 | Dasi et al. | May 2021 | A1 |
20210161688 | Shahriari | Jun 2021 | A1 |
20210177583 | Colavito et al. | Jun 2021 | A1 |
20210177584 | Levi et al. | Jun 2021 | A1 |
20210177587 | Braido | Jun 2021 | A1 |
20210186689 | Eidenschink et al. | Jun 2021 | A1 |
20210228343 | Scheinblum et al. | Jul 2021 | A1 |
20210378823 | Argento et al. | Dec 2021 | A1 |
20210401572 | Nasar et al. | Dec 2021 | A1 |
20220054261 | Argento et al. | Feb 2022 | A1 |
20220175522 | Salahieh et al. | Jun 2022 | A1 |
20220257373 | Yang et al. | Aug 2022 | A1 |
20220401214 | Saul | Dec 2022 | A1 |
20230044256 | Salahleh | Feb 2023 | A1 |
20230105492 | Argento et al. | Apr 2023 | A1 |
20230118748 | Argento | Apr 2023 | A1 |
20230165679 | Boyd et al. | Jun 2023 | A1 |
Number | Date | Country |
---|---|---|
2012261727 | Oct 2015 | AU |
2019246822 | Aug 2020 | AU |
2020227034 | Sep 2020 | AU |
PI0820603 | Jun 2020 | BR |
2979817 | Sep 2016 | CA |
2954826 | Oct 2019 | CA |
103764216 | Apr 2014 | CN |
103974670 | Aug 2014 | CN |
105358098 | Feb 2016 | CN |
111110401 | May 2020 | CN |
111110403 | May 2020 | CN |
108601655 | Jun 2020 | CN |
111265335 | Jun 2020 | CN |
111278389 | Jun 2020 | CN |
111329541 | Jun 2020 | CN |
19857887 | May 2005 | DE |
102014102650 | Sep 2015 | DE |
1432369 | Feb 2008 | EP |
2374415 | Oct 2011 | EP |
2907479 | Aug 2015 | EP |
3037064 | Jun 2016 | EP |
3342355 | Jul 2018 | EP |
3395296 | Oct 2018 | EP |
3406225 | Nov 2018 | EP |
3417831 | Dec 2018 | EP |
3476366 | May 2019 | EP |
3482718 | May 2019 | EP |
2637607 | Oct 2019 | EP |
3554424 | Oct 2019 | EP |
3244809 | Feb 2020 | EP |
3639792 | Apr 2020 | EP |
3417831 | May 2020 | EP |
3649963 | May 2020 | EP |
2072027 | Jun 2020 | EP |
3441045 | Jul 2020 | EP |
3672528 | Jul 2020 | EP |
3554423 | Aug 2020 | EP |
3107498 | Sep 2020 | EP |
3570782 | Sep 2020 | EP |
3700467 | Sep 2020 | EP |
3705090 | Sep 2020 | EP |
3782585 | Feb 2021 | EP |
H08131551 | May 1996 | JP |
2004154177 | Jun 2004 | JP |
2008018139 | Jan 2008 | JP |
2011506017 | Mar 2011 | JP |
2012531270 | Dec 2012 | JP |
2020515375 | May 2020 | JP |
2020517379 | Jun 2020 | JP |
2020520729 | Jul 2020 | JP |
6735294 | Aug 2020 | JP |
2020032237 | Mar 2020 | KR |
2020033349 | Mar 2020 | KR |
2020033350 | Mar 2020 | KR |
202027694 | Aug 2020 | TW |
WO2007007873 | Jan 2007 | WO |
WO2007081820 | Jul 2007 | WO |
WO2010141847 | Dec 2010 | WO |
WO2011025945 | Mar 2011 | WO |
WO2012087842 | Jun 2012 | WO |
WO2012145545 | Oct 2012 | WO |
WO2013190910 | Dec 2013 | WO |
WO2015127264 | Aug 2015 | WO |
WO2015173609 | Nov 2015 | WO |
WO2015195823 | Dec 2015 | WO |
WO2016052145 | Apr 2016 | WO |
WO2016117169 | Jul 2016 | WO |
WO2016183485 | Nov 2016 | WO |
WO2017121193 | Jul 2017 | WO |
WO2017151566 | Sep 2017 | WO |
WO2017214098 | Dec 2017 | WO |
WO2018025260 | Feb 2018 | WO |
WO2018039561 | Mar 2018 | WO |
WO2018039589 | Mar 2018 | WO |
WO2018112429 | Jun 2018 | WO |
WO2018119304 | Jun 2018 | WO |
WO2018178966 | Oct 2018 | WO |
WO2018178967 | Oct 2018 | WO |
WO2018187390 | Oct 2018 | WO |
WO2018192197 | Oct 2018 | WO |
WO2019010370 | Jan 2019 | WO |
WO2019036592 | Feb 2019 | WO |
WO2019062366 | Apr 2019 | WO |
WO2019081777 | May 2019 | WO |
WO2019086958 | May 2019 | WO |
WO2019102484 | May 2019 | WO |
WO2019116369 | Jun 2019 | WO |
WO2019118371 | Jun 2019 | WO |
WO2019135011 | Jul 2019 | WO |
WO2019135028 | Jul 2019 | WO |
WO2019144036 | Jul 2019 | WO |
WO2019147504 | Aug 2019 | WO |
WO2019147846 | Aug 2019 | WO |
WO2019154124 | Aug 2019 | WO |
WO2019164516 | Aug 2019 | WO |
WO2019195860 | Oct 2019 | WO |
WO2019209927 | Oct 2019 | WO |
WO2019222694 | Nov 2019 | WO |
WO2019241777 | Dec 2019 | WO |
WO2020051147 | Mar 2020 | WO |
WO2020051591 | Mar 2020 | WO |
WO2020072199 | Apr 2020 | WO |
WO2020072201 | Apr 2020 | WO |
WO2020073050 | Apr 2020 | WO |
WO2020123719 | Jun 2020 | WO |
WO2020132590 | Jun 2020 | WO |
WO2020157018 | Aug 2020 | WO |
WO2020163112 | Aug 2020 | WO |
WO2020236830 | Nov 2020 | WO |
WO2020247907 | Dec 2020 | WO |
WO2021021482 | Feb 2021 | WO |
WO2021028867 | Feb 2021 | WO |
WO2021034497 | Feb 2021 | WO |
WO2021086850 | May 2021 | WO |
WO2021091754 | May 2021 | WO |
WO2021113143 | Jun 2021 | WO |
WO2021178560 | Sep 2021 | WO |
WO2021183610 | Sep 2021 | WO |
WO2021257278 | Dec 2021 | WO |
WO2021257722 | Dec 2021 | WO |
WO2022010974 | Jan 2022 | WO |
WO2022046678 | Mar 2022 | WO |
WO2022047095 | Mar 2022 | WO |
WO2022047160 | Mar 2022 | WO |
WO2022047274 | Mar 2022 | WO |
WO2022047393 | Mar 2022 | WO |
WO2022047395 | Mar 2022 | WO |
Entry |
---|
Schaefer; Large heart valves—small heart valves; ISMAAP; Oct. 19, 2015; 5 pages; retrieved from the internet (https://www.ismaap.org/condition-detail/large-heart-valves-small-heart-valves/) on Mar. 21, 2023. |
Argento et al.; U.S. Appl. No. 17/931,408 entitled “Prosthetic cardiac valve devices, systems, and methods,”, filed Sep. 12, 2022. |
Argento et al.; U.S. Appl. No. 18/002,219 entitled “Minimal frame prosthetic cardiac valve delivery devices, systems, and methods,”, filed Dec. 16, 2022. |
Backus et al.; U.S. Appl. No. 18/004,609 entitled “Valve delivery system,” filed Jan. 6, 2023. |
Mulcahy et al.; U.S. Appl. No. 18/043,480 entitled “Prosthetic cardiac valve delivery devices, systems, and methods,”, filed Feb. 28, 2023. |
Adamek-Bowers et al.; U.S. Appl. No. 18/043,499 entitled “Interface for prosthetic cardiac valve and delivery systems,”, filed Feb. 28, 2023. |
Salahieh et al.; U.S. Appl. No. 18/043,519 entitled “Flared prosthetic cardiac valve delivery devices and systems,”, filed Feb. 28, 2023. |
Scott et al.; U.S. Appl. No. 18/043,526 entitled “Access sheath for prosthetic cardiac valve delivery systems,”, filed Feb. 28, 2023. |
Yang et al.; U.S. Appl. No. 18/043,542 entitled “Anchor for prosthetic cardiac valve devices,”, filed Feb. 28, 2023. |
Argento et al.; U.S. Appl. No. 18/246,307 entitled “Systems, methods, and devices for expandable sensors,”, filed Mar. 22, 2023. |
Argento et al.; U.S. Appl. No. 18/246,311 entitled “Prosthetic cardiac valve sensor devices, systems, and methods with imaging,” filed Mar. 22, 2023. |
Westaby et al.; Adult human valve dimensions and their surgical significance; The American Journal of Cardiology; 53(4); pp. 552-556; Feb. 1984. |
Argento et al.; U.S. Appl. No. 18/185,330 entitled “Prosthetic cardiac valve devices, systems, and methods,”, filed Mar. 16, 2023. |
Adamek-Bowers et al.; U.S. Appl. No. 18/255,763 entitled “Mitral valve implants,”, filed Jun. 2, 2023. |
Argento et al.; U.S. Appl. No. 18/494,520 entitled “Prosthetic cardiac valve devices, systems, and methods,”, filed Oct. 25, 2023. |
Number | Date | Country | |
---|---|---|---|
20230310147 A1 | Oct 2023 | US |
Number | Date | Country | |
---|---|---|---|
63072788 | Aug 2020 | US |